Therapy News and Research

RSS

Breast Cancer Now-funded research aims to improve quality of care for black women with breast cancer

Researchers are investigating how to improve the quality of care for black women with breast cancer and reduce health inequalities, thanks to funding from Breast Cancer Now.

2 Aug 2023

New treatment offers hope for children suffering from rare skin condition

It’s a beautiful moniker, but for Australia’s ‘butterfly children’ it belies a devastating reality filled with enormous pain and suffering caused by a rare skin condition – Epidermolysis Bullosa (EB).

2 Aug 2023

Pet ownership and care can support communication, wellbeing for people with aphasia

Feathers, fins or fur, all pets can make us feel happier. Now, new research from the University of South Australia shows that pet ownership and pet care can also support communication and wellbeing, especially for people with acquired language difficulties such as aphasia.

2 Aug 2023

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Decades of research have left knowledge gaps about cells that regulate the immune system: Purdue and NIH.

1 Aug 2023

Non-invasive brain stimulation shows promise for treating ADHD in children

Non-invasive brain stimulation, combined with cognitive training, could significantly improve symptoms of attention deficit hyperactivity disorder (ADHD) in children, according to new research jointly led by the University of Surrey and the Hebrew University of Jerusalem.

1 Aug 2023

Low-dose atropine eyedrops not effective in slowing myopia progression in children

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

1 Aug 2023

Penn Medicine and CHOP receive $26 million NIH grant to develop treatments for three rare genetic diseases

A Penn Medicine and Children's Hospital of Philadelphia (CHOP) team will seek to develop treatments for three rare, incurable genetic diseases with the help of a $26 million grant from the National Institutes of Health (NIH).

1 Aug 2023

ICI therapy linked to unique immune response in arthritis

Immune checkpoint inhibitor (ICI) therapies used to treat cancer come with the risk of adverse autoimmune responses, including arthritis that can persist for years and require joint replacement surgery.

1 Aug 2023

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

1 Aug 2023

The effects of oxidative stress on women’s fertility

Scientists review existing literature to assess the relationship between oxidative stress and female infertility.

1 Aug 2023

Do vegetarian diets improve the cardiometabolic profile of people with or at high risk of cardiovascular diseases?

The role of vegetarian diets in promoting glycemic control and weight changes in the prevention and management of cardiovascular diseases.

1 Aug 2023

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Researchers compared the shared genetic risk and biological foundations of neurological and mental illnesses.

1 Aug 2023

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

Study examined the role of plasma metagenomic next-generation sequencing.

1 Aug 2023

SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Researchers reported on lentiviral pseudovirions pseudotyped with SARS-CoV-2.

1 Aug 2023

Two new subtypes of HPV+ head and neck cancers identified

Cases of human papillomavirus (HPV)-associated cancers of the head and neck, known as head and neck squamous cell carcinoma (HNSCC), are rapidly increasing throughout the United States.

31 Jul 2023

Tiny amounts of hydrogen sulfide could help people live healthier for longer

Future therapies to help people live healthy lives for longer could be developed from drugs that release tiny amounts of the gas hydrogen sulfide (H2S), new research has indicated.

31 Jul 2023

Early antiplatelet medication linked to improved stroke recovery

Administering antiplatelet medication within 24 hours of mechanical thrombectomy, an effective procedure for stroke, may help patients more successfully recover and prevent high-risk individuals from experiencing additional strokes, according to a study presented today at the Society of NeuroInterventional Surgery's (SNIS) 20th Annual Meeting.

31 Jul 2023

Newly identified protein plays a key role in the action of emerging anticancer therapies

Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

31 Jul 2023

Scrambler therapy: A new non-invasive treatment for chronic pain

A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a noninvasive pain treatment, can yield significant relief for approximately 80%–90% of patients with chronic pain, and it may be more effective than another noninvasive therapy: transcutaneous electrical nerve stimulation (TENS).

31 Jul 2023

Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma

Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.

31 Jul 2023

Therapy News and Research

Breast Cancer Now-funded research aims to improve quality of care for black women with breast cancer

New treatment offers hope for children suffering from rare skin condition

Pet ownership and care can support communication, wellbeing for people with aphasia

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Non-invasive brain stimulation shows promise for treating ADHD in children

Low-dose atropine eyedrops not effective in slowing myopia progression in children

Penn Medicine and CHOP receive $26 million NIH grant to develop treatments for three rare genetic diseases

ICI therapy linked to unique immune response in arthritis

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

The effects of oxidative stress on women’s fertility

Do vegetarian diets improve the cardiometabolic profile of people with or at high risk of cardiovascular diseases?

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Two new subtypes of HPV+ head and neck cancers identified

Tiny amounts of hydrogen sulfide could help people live healthier for longer

Early antiplatelet medication linked to improved stroke recovery

Newly identified protein plays a key role in the action of emerging anticancer therapies

Scrambler therapy: A new non-invasive treatment for chronic pain

Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News